[ad_1]
Copy link
The Saudi Ministry of Health announced Thursday that Vitrakvi, the first cancer treatment, is known as Larotrectinib.
"This medicine does not completely cure cancer or completely cure it, but it aims to control its growth and spread for as long as possible and does not replace surgery, chemotherapy and radiation therapy. "said the ministry via his official account on Twitter.
"The New England Journal of Medicine has published a study on larotrectinib.This study was in its first and second stages.It involved 55 patients with cancer and carriers of a genetic mutation in the TRK. , with a full response rate of 13% and a partial response rate of 62%. "
"This is not a long-term answer for all patients because the disease has developed in some study participants and continued to respond in 39% of patients after the first year treatment and some patients were operated on after treatment. "
The new treatment has recently been approved by the Food and Drug Administration (FDA) to treat specific cases of cancer with a specific type of rare genetic mutations (TRK gene). This rare mutation is present in some tumors, such as salivary glands, thyroid, lungs and connective tissue. Cases that contain a genetic mutation do not tolerate surgery, as well as those that contain a genetic mutation and there is no alternative appropriate to the treatment, nor cases that appear after the prescribed treatment.
Vitrakvi depends on the treatment of genetic mutations of cancerous tumors, regardless of the type or location of the disease.
Scott Gottlieb, Commissioner of the US Commission "NBC News," said: "Ratification of this drug is an important step in the treatment of cancer because it treats at the source and treats the baseline of cancerous tumors, no matter what the place of origin in the human body ".
Gottlieb said the new drug will help cancer patients finally get the right treatment at the right time.
Viagracafe will help treat people with different cancerous tumors, but with common genetic mutations.
[ad_2]
Source link